BM
BioMarin Pharmaceutical
BMRN · NASDAQ
$66.53 +0.66% (+$0.44)
1M +4.26%
Market Cap $12.8B
P/E Ratio 175.96x
Div. Yield -
ROE 1.18%
Bulios Fair Price
$68.43
2.9% upside
Trenutna cena
$66.53
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica BMRN trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
36 /100
Fair P/FCF 17.52x
P/E 175.96x
P/B 2.03x
Growth
94 /100
Growing FCF growth 136.30%
EPS growth 33.89%
Book val. growth 9.76%
Profitability
64 /100
Moderate Op. margin 8.02%
Gross margin 75.55%
FCF margin 21.51%
Quality
7 /100
Poor ROA 0.62%
ROIC 1.25%
Asset turnover 0.29x
Debt
43 /100
Moderate Int. coverage 2.78x
Debt/Equity 0.66x
Net debt/EBITDA 8.63x
Stability
42 /100
Moderate EPS volatility 89.43%
Beta 0.23x
Profitable years 4
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BMRN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alexander Hardy
Employees
3,221
Headquarters
San Rafael
Prihajajoči dogodki
26 OKT.
Earnings
Upcoming earnings report